Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CTMX

CytomX Therapeutics Inc

May 08 • 11:22AM ET

4.01

+0.01 0.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR ZYME STRO JANX NRIX

| Held by: VTI XBI VXF IBB FDM VHT FFSM LABU DFAS IDNA

Scroll to Statements

Index	-	P/E	441.21	EPS (ttm)	0.01	Insider Own	21.63%	Shs Outstand	170.19M	Perf Week	-3.95%
Market Cap	867.95M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	-0.62%	Shs Float	169.43M	Perf Month	-5.31%
Enterprise Value	735.14M	PEG	-	EPS next Q	-0.09	Inst Own	61.07%	Short Float	16.24%	Perf Quarter	-29.19%
Income	-20.37M	P/S	11.39	EPS this Y	-219.35%	Inst Trans	5.00%	Short Ratio	4.08	Perf Half Y	-4.63%
Sales	76.20M	P/B	6.90	EPS next Y	-14.90%	ROA	-12.62%	Short Interest	27.52M	Perf YTD	-5.75%
Book/sh	0.58	P/C	6.33	EPS next 5Y	-	ROE	-35.25%	52W High	8.21 -51.10%	Perf Year	268.35%
Cash/sh	0.63	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-17.54%	52W Low	0.91 342.08%	Perf 3Y	138.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	98.19%	Volatility	5.50% 5.87%	Perf 5Y	-53.04%
Dividend TTM	-	EV/Sales	9.65	EPS Y/Y TTM	-97.67%	Oper. Margin	-29.48%	ATR (14)	0.29	Perf 10Y	-66.85%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-44.82%	Profit Margin	-26.73%	RSI (14)	38.85	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	-173.57%	SMA20	-8.31%	Beta	2.16	Target Price	13.67
Payout	-	Debt/Eq	0.04	Sales Q/Q	-98.26%	SMA50	-12.51%	Rel Volume	0.92	Prev Close	4.00
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	3.43%	Avg Volume	6.75M	Price	4.01
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	2,004,037	Change	0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)